Clinical Trials in New York

Showing 6641-6660 of 22,668 trials

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

NCT05896878

This is a research study to evaluate the effectiveness of daily supplementation with Root.Health, a plant-based dietary supplement, on reducing levels of 11 abnormal urine biomarkers associated with chronic pain. Biomarkers are molecules found in blood, tissues, or other body fluids (such as urine) that indicate normal or abnormal processes.

Pain, ChronicOpioid DependenceOpioid Use+1 more

Hudson Medical1 participantsStarted Jul 2023

New York, New York, United States

TERMINATEDPhase 3< 1 mile

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

NCT03302494

The WAVECREST 2 trial is a prospective, multicenter, randomized, active controlled, clinical trial to evaluate the safety and effectiveness of the Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.

Stroke

Coherex Medical248 participantsStarted Dec 2017

Birmingham, Alabama, United States • Chandler, Arizona, United States • Los Angeles, California, United States +22 more locations

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Find Trials by Condition in New York

Brain Injury Rehabilitation Improving the Transition Experience

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Transspinal Stimulation Plus Locomotor Training for SCI

CryoBalloon Ablation for Treatment of Duodenal Adenomas

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Intervention to Enhance PrEP Persistence

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial